CRH and major depressive disorder: The main finding was that four weeks of intervention with escitalopram 10 mg/day compared with placebo had no statistically significant effect on neuroendocrine responses in the HPA-axis, as measured by ΔCorAUCtotal in the DEX-CRH test, in healthy first-degree relatives of patients with MDD.